Pancreatic Cancer Research

ResearcherPrincess Margaret Cancer CentreNo recent work listed

David Benjamin Shultz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8242-6555; OpenAlex author ID A5061702922. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper

Papers 2

  1. A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3. Co-author DOI 10.1371/journal.pone.0147995↗
  2. Postradiotherapy CA19-9 kinetics correlate with outcomes in patients with pancreatic adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000098↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Albert C. Koong · 2 shared papers, 2014–2016 · strength 0.11
  2. Daniel Tandel Chang · 2 shared papers, 2014–2016 · strength 0.11
  3. Gregory M. Heestand · 1 shared paper, 2016 · strength 0.05
  4. Wendy R. Parulekar · 1 shared paper, 2016 · strength 0.05
  5. Malcolm J. Moore · 1 shared paper, 2016 · strength 0.05
  6. Pamela L. Kunz · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.